{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T20:17:06Z","timestamp":1790626626653,"version":"4.1.0"},"reference-count":45,"publisher":"American Society for Microbiology","issue":"9","license":[{"start":{"date-parts":[[2009,9,1]],"date-time":"2009-09-01T00:00:00Z","timestamp":1251763200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.asm.org\/non-commercial-tdm-license"}],"content-domain":{"domain":["journals.asm.org"],"crossmark-restriction":true},"short-container-title":["Clin Vaccine Immunol"],"published-print":{"date-parts":[[2009,9]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n          <jats:p>\n            The immunogenicity and protective efficacy of a recombinant subunit West Nile virus (WNV) vaccine was evaluated in rhesus macaques (\n            <jats:italic>Macaca mulatta<\/jats:italic>\n            ). The vaccine consisted of a recombinant envelope (E) protein truncated at the C-terminal end, resulting in a polypeptide containing 80% of the N-terminal amino acids of the native WNV protein (WN-80E), mixed with an adjuvant (GPI-0100). WN-80E was produced in a\n            <jats:italic>Drosophila melanogaster<\/jats:italic>\n            expression system with high yield and purified by immunoaffinity chromatography using a monoclonal antibody specific for flavivirus E proteins. Groups of monkeys were vaccinated with formulations containing 1 or 25 \u03bcg of WN-80E antigen, and both humoral and cellular immunity were assessed after vaccination. The results demonstrated potent antibody responses to vaccination, as determined by both enzyme-linked immunosorbent assay and virus-neutralizing antibody assays. All vaccinated animals responded favorably, and there was little difference in response between animals immunized with 1 or 25 \u03bcg of WN-80E. Cellular immunity was determined by lymphocyte proliferation and cytokine production assays using peripheral blood mononuclear cells from vaccinated animals stimulated in vitro with WN-80E. Cell-mediated immune responses varied from animal to animal within each group. About half of the animals responded with lymphoproliferation, cytokine production, or both. Again, there was little difference in response between animals immunized with a 1- or 25-\u03bcg dose of WN-80E in the vaccine formulations. In a separate experiment, groups of monkeys were immunized with the WN-80E\/GPI-0100 vaccine or an adjuvant-only control formulation. Animals were then challenged by inoculation of wild-type WNV, and the level of viremia in each animal was monitored daily for 10 days. The results showed that whereas all animals in the control group had detectable viremia for at least 3 days after challenge, all of the vaccinated animals were negative on all days after challenge. Thus, the WN-80E vaccine was 100% efficacious in protecting monkeys against infection with WNV.\n          <\/jats:p>","DOI":"10.1128\/cvi.00119-09","type":"journal-article","created":{"date-parts":[[2009,7,30]],"date-time":"2009-07-30T01:46:51Z","timestamp":1248918411000},"page":"1332-1337","update-policy":"https:\/\/doi.org\/10.1128\/asmj-crossmark-policy-page","source":"Crossref","is-referenced-by-count":68,"title":["Immunogenicity and Protective Efficacy of a Recombinant Subunit West Nile Virus Vaccine in Rhesus Monkeys"],"prefix":"10.1128","volume":"16","author":[{"given":"Michael M.","family":"Lieberman","sequence":"first","affiliation":[{"name":"Hawaii Biotech, Inc., Aiea, Hawaii"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vivek R.","family":"Nerurkar","sequence":"additional","affiliation":[{"name":"Department of Tropical Medicine, Medical Microbiology and Pharmacology, John A. Burns School of Medicine, University of Hawaii at Manoa, Honolulu, Hawaii"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haiyan","family":"Luo","sequence":"additional","affiliation":[{"name":"Department of Tropical Medicine, Medical Microbiology and Pharmacology, John A. Burns School of Medicine, University of Hawaii at Manoa, Honolulu, Hawaii"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruce","family":"Cropp","sequence":"additional","affiliation":[{"name":"Department of Tropical Medicine, Medical Microbiology and Pharmacology, John A. Burns School of Medicine, University of Hawaii at Manoa, Honolulu, Hawaii"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"Jr.","given":"Ricardo","family":"Carrion","sequence":"additional","affiliation":[{"name":"Southwest Foundation for Biomedical Research, San Antonio, Texas"},{"name":"Southwest National Primate Research Center, San Antonio, Texas"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melissa","family":"de la Garza","sequence":"additional","affiliation":[{"name":"Southwest Foundation for Biomedical Research, San Antonio, Texas"},{"name":"Southwest National Primate Research Center, San Antonio, Texas"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beth-Ann","family":"Coller","sequence":"additional","affiliation":[{"name":"Hawaii Biotech, Inc., Aiea, Hawaii"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Clements","sequence":"additional","affiliation":[{"name":"Hawaii Biotech, Inc., Aiea, Hawaii"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven","family":"Ogata","sequence":"additional","affiliation":[{"name":"Hawaii Biotech, Inc., Aiea, Hawaii"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teri","family":"Wong","sequence":"additional","affiliation":[{"name":"Hawaii Biotech, Inc., Aiea, Hawaii"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tim","family":"Martyak","sequence":"additional","affiliation":[{"name":"Hawaii Biotech, Inc., Aiea, Hawaii"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolyn","family":"Weeks-Levy","sequence":"additional","affiliation":[{"name":"Hawaii Biotech, Inc., Aiea, Hawaii"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"235","reference":[{"key":"e_1_3_2_2_2","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.76.24.13097-13100.2002"},{"key":"e_1_3_2_3_2","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1097\/QCO.0b013e32816b5cad","volume":"20","year":"2007","unstructured":"Bowen, R. A., and N. M. Nemeth. 2007. Experimental infections with West Nile virus. Curr. Opin. Infect. Dis.20:293-297.","journal-title":"Curr. Opin. Infect. Dis."},{"key":"e_1_3_2_4_2","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/S1473-3099(02)00368-7","volume":"2","year":"2002","unstructured":"Campbell, G. L., A. A. Marfin, R. S. Lanciotti, and D. J. Gubler. 2002. West Nile virus. Lancet Infect. Dis.2:519-529.","journal-title":"Lancet Infect. Dis."},{"key":"e_1_3_2_5_2","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1086\/506939","volume":"43","year":"2006","unstructured":"Carson, P. J., P. Konewko, K. S. Wold, P. Mariani, S. Goli, P. Bergloff, and R. D. Crosby. 2006. Long-term clinical and neuropsychological outcomes of West Nile virus infection. Clin. Infect. Dis.43:723-730.","journal-title":"Clin. Infect. Dis."},{"key":"e_1_3_2_6_2","doi-asserted-by":"crossref","first-page":"675","DOI":"10.3201\/eid0704.017414","volume":"7","year":"2001","unstructured":"Chowers, M. Y., R. Lang, F. Nassar, D. Ben-David, M. Giladi, E. Rubinshtein, A. Itzhaki, J. Mishal, Y. Siegman-Igra, R. Kitzes, N. Pick, Z. Landau, D. Wolf, H. Bin, E. Mendelson, S. D. Pitlik, and M. Weinberger. 2001. Clinical characteristics of the West Nile fever outbreak, Israel, 2000. Emerg. Infect. Dis.7:675-678.","journal-title":"Emerg. Infect. Dis."},{"key":"e_1_3_2_7_2","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.75.16.7769-7773.2001"},{"key":"e_1_3_2_8_2","doi-asserted-by":"publisher","DOI":"10.1128\/CDLI.8.6.1150-1155.2001"},{"key":"e_1_3_2_9_2","first-page":"105","volume":"14","year":"2003","unstructured":"Drebot, M. A., L. R. Lindsay, I. K. Barker, P. A. Buck, M. Fearon, F. Hunter, P. Sockett, and H. Artsob. 2003. West Nile virus surveillance and diagnosis: a Canadian perspective. Can. J. Infect. Dis.14:105-114.","journal-title":"Can. J. Infect. Dis."},{"key":"e_1_3_2_10_2","doi-asserted-by":"crossref","first-page":"1604","DOI":"10.3201\/eid0912.030564","volume":"9","year":"2003","unstructured":"Estrada-Franco, J. G., R. Navarro-Lopez, D. W. Beasley, L. Coffey, A. S. Carrara, A. Travassos da Rosa, T. Clements, E. Wang, G. V. Ludwig, A. C. Cortes, P. P. Ram\u00edrez, R. B. Tesh, A. D. Barrett, and S. C. Weaver. 2003. West Nile virus in Mexico: evidence of widespread circulation since July 2002. Emerg. Infect. Dis.9:1604-1607.","journal-title":"Emerg. Infect. Dis."},{"key":"e_1_3_2_11_2","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1016\/j.humpath.2004.04.008","volume":"35","year":"2004","unstructured":"Guarner, J., W.-J. Shieh, S. Hunter, C. D. Paddock, T. Morken, G. L. Campbell, A. A. Marfin, and S. R. Zaki. 2004. Clinicopathologic study and laboratory diagnosis of 23 cases with West Nile virus encephalomyelitis. Hum. Pathol.35:983-990.","journal-title":"Hum. Pathol."},{"key":"e_1_3_2_12_2","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1542\/peds.113.5.1375","volume":"113","year":"2004","unstructured":"Hayes, E. B., and D. R. O'Leary. 2004. West Nile virus infection: a pediatric perspective. Pediatrics113:1375-1381.","journal-title":"Pediatrics"},{"key":"e_1_3_2_13_2","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.3201\/eid1108.050289a","volume":"11","year":"2005","unstructured":"Hayes, E. B., N. Komar, R. S. Nasci, S. P. Montgomery, D. R. O'Leary, and G. L. Campbell. 2005. Epidemiology and transmission dynamics of West Nile virus disease. Emerg. Infect. Dis.11:1167-1173.","journal-title":"Emerg. Infect. Dis."},{"key":"e_1_3_2_14_2","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.3201\/eid1108.050289b","volume":"11","year":"2005","unstructured":"Hayes, E. B., J. J. Sejvar, S. R. Zaki, R. S. Lanciotti, A. V. Bode, and G. L. Campbell. 2005. Virology, pathology, and clinical manifestations of West Nile virus disease. Emerg. Infect. Dis.11:1174-1179.","journal-title":"Emerg. Infect. Dis."},{"key":"e_1_3_2_15_2","doi-asserted-by":"crossref","first-page":"643","DOI":"10.3201\/eid0505.990505","volume":"5","year":"1999","unstructured":"Hubalek, Z., and J. Halouzka. 1999. West Nile fever\u2014a reemerging mosquito-borne viral disease in Europe. Emerg. Infect. Dis.5:643-650.","journal-title":"Emerg. Infect. Dis."},{"key":"e_1_3_2_16_2","doi-asserted-by":"crossref","first-page":"5338","DOI":"10.1016\/j.vaccine.2008.08.011","volume":"26","year":"2008","unstructured":"Jarvi, S. I., M. M. Lieberman, E. Hofmeister, V. R. Nerurkar, T. Wong, and C. Weeks-Levy. 2008. Protective efficacy of a recombinant subunit West Nile virus vaccine in domestic geese (Anser anser). Vaccine26:5338-5344.","journal-title":"Vaccine"},{"key":"e_1_3_2_17_2","doi-asserted-by":"crossref","first-page":"1918","DOI":"10.3201\/eid1312.061265","volume":"13","year":"2007","unstructured":"Jean, C. M., S. Honarmand, J. K. Louie, and C. A. Glasser. 2007. Risk factors for West Nile virus neuroinvasive disease, California, 2005. Emerg. Infect. Dis.13:1918-1920.","journal-title":"Emerg. Infect. Dis."},{"key":"e_1_3_2_18_2","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1590\/S1020-49892006000200006","volume":"19","year":"2006","unstructured":"Komar, N., and G. G. Clark. 2006. West Nile virus activity in Latin America and the Caribbean. Rev. Panam. Salud Publica19:112-117.","journal-title":"Rev. Panam. Salud Publica"},{"key":"e_1_3_2_19_2","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1097\/01.TP.0000101435.91619.31","volume":"77","year":"2004","unstructured":"Kumar, D., G. V. R. Prasad, J. Zaltzman, G. A. Levy, and A. Humar. 2004. Community-acquired West Nile virus infection in solid-organ transplant recipients. Transplantation77:399-402.","journal-title":"Transplantation"},{"key":"e_1_3_2_20_2","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/j.vaccine.2006.08.018","volume":"25","year":"2007","unstructured":"Lieberman, M. M., D. E. Clements, S. Ogata, G. Wang, G. Corpuz, T. Wong, T. Martyak, L. Gilson, B.-A. Coller, J. Leung, D. M. Watts, R. B. Tesh, M. Siirin, A. Travassos da Rosa, T. Humphreys, and C. Weeks-Levy. 2007. Preparation and immunogenic properties of a recombinant West Nile subunit vaccine. Vaccine25:414-423.","journal-title":"Vaccine"},{"key":"e_1_3_2_21_2","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.77.4.2600-2606.2003"},{"key":"e_1_3_2_22_2","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1089\/vim.2000.13.401","volume":"13","year":"2000","unstructured":"Lustig, S., U. Olshevsky, D. Ben-Nathan, B. E. Lachmi, M. Malkinson, D. Kobiler, and M. Halevy. 2000. A live attenuated West Nile virus strain as a potential veterinary vaccine. Viral. Immunol.13:401-410.","journal-title":"Viral. Immunol."},{"key":"e_1_3_2_23_2","doi-asserted-by":"crossref","first-page":"3961","DOI":"10.1016\/S0264-410X(03)00298-6","volume":"21","year":"2003","unstructured":"Marciani, D. J., R. C. Reynolds, A. K. Pathak, K. Finley-Woodman, and R. D. May. 2003. Fractionation, structural studies, and immunological characterization of the semi-synthetic Quillaja saponins derivative GPI-0100. Vaccine21:3961-3971.","journal-title":"Vaccine"},{"key":"e_1_3_2_24_2","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/S0264-410X(00)00038-4","volume":"18","year":"2000","unstructured":"Markoff, L. 2000. Points to consider in the development of a surrogate for efficacy of novel Japanese encephalitis virus vaccines. Vaccine18:26-32.","journal-title":"Vaccine"},{"key":"e_1_3_2_25_2","first-page":"221","volume":"18","year":"2004","unstructured":"Minke, J. M., L. Siger, K. Karaca, L. Austgen, P. Gordy, R. Bowen, R. W. Renshaw, S. Loosmore, J. C. Audonnet, and B. Nordgren. 2004. Recombinant canarypoxvirus vaccine carrying the prM\/E genes of West Nile virus protects horses against a West Nile virus-mosquito challenge. Arch. Virol. Suppl.18:221-230.","journal-title":"Arch. Virol. Suppl."},{"key":"e_1_3_2_26_2","doi-asserted-by":"crossref","first-page":"6986","DOI":"10.1073\/pnas.0832193100","volume":"100","year":"2003","unstructured":"Modis, Y., S. Ogata, D. Clements, and S. C. Harrison. 2003. A ligand-binding pocket in the dengue virus envelope glycoprotein. Proc. Natl. Acad. Sci. USA100:6986-6991.","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"e_1_3_2_27_2","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1038\/nature02165","volume":"427","year":"2004","unstructured":"Modis, Y., S. Ogata, D. Clements, and S. C. Harrison. 2004. Structure of the dengue virus envelope protein after membrane fusion. Nature427:313-319.","journal-title":"Nature"},{"key":"e_1_3_2_28_2","doi-asserted-by":"crossref","first-page":"37","DOI":"10.2174\/1568005013343254","volume":"1","year":"2001","unstructured":"Monath, T. P., J. Arroyo, C. Miller, and F. Guirakhoo. 2001. West Nile virus vaccine. Curr. Drug Targets Infect. Disord.1:37-50.","journal-title":"Curr. Drug Targets Infect. Disord."},{"key":"e_1_3_2_29_2","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/S0140-6736(01)05480-0","volume":"358","year":"2001","unstructured":"Mostashari, F., M. L. Bunning, P. T. Kitsutani, D. A. Singer, D. Nash, M. J. Cooper, N. Katz, K. A. Liljebjelke, B. J. Biggerstaff, A. D. Fine, M. C. Layton, S. M. Mullin, A. J. Johnson, D. A. Martin, E. B. Hayes, and G. L. Campbell. 2001. Epidemic West Nile encephalitis, New York, 1999: results of a household-based seroepidemiological survey. Lancet358:261-264.","journal-title":"Lancet"},{"key":"e_1_3_2_30_2","doi-asserted-by":"crossref","first-page":"712","DOI":"10.3201\/eid1004.030675","volume":"10","year":"2004","unstructured":"Olberg, R.-A., I. K. Barker, G. J. Crawshaw, M. F. Bertelsen, M. A. Drebot, and M. Andonova. 2004. West Nile virus encephalitis in a Barbary Macaque (Macaca sylvanus). Emerg. Infect. Dis.10:712-714.","journal-title":"Emerg. Infect. Dis."},{"key":"e_1_3_2_31_2","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1089\/153036604773083004","volume":"4","year":"2004","unstructured":"O'Leary, D. R., A. A. Marfin, S. P. Montgomery, A. M. Kipp, J. A. Lehman, B. J. Biggerstaff, V. L. Elko, P. D. Collins, J. E. Jones, and G. L. Campbell. 2004. The epidemic of West Nile Virus in the United States, 2002. Vector Borne Zoonotic Dis.4:61-70.","journal-title":"Vector Borne Zoonotic Dis."},{"key":"e_1_3_2_32_2","doi-asserted-by":"crossref","first-page":"611","DOI":"10.3201\/eid0704.017401","volume":"7","year":"2001","unstructured":"Petersen, L. R., and J. T. Roehrig. 2001. West Nile virus: a reemerging global pathogen. Emerg. Infect. Dis.7:611-614.","journal-title":"Emerg. Infect. Dis."},{"key":"e_1_3_2_33_2","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1056\/NEJMo020128","volume":"347","year":"2002","unstructured":"Petersen, L. R., J. T. Roehrig, and J. M. Hughes. 2002. West Nile virus encephalitis. N. Engl. J. Med.347:1225-1226.","journal-title":"N. Engl. J. Med."},{"key":"e_1_3_2_34_2","doi-asserted-by":"crossref","first-page":"128","DOI":"10.3201\/eid0701.010118","volume":"7","year":"2001","unstructured":"Platonov, A. E., G. A. Shipulin, O. Y. Shipulina, E. N. Tyutyunnik, T. I. Frolochkina, R. S. Lanciotti, S. Yazyshina, O. V. Platonova, I. L. Obukhov, A. N. Zhukov, Y. Y. Vengerov, and V. I. Pokrovskii. 2001. Outbreak of West Nile virus infection, Volgograd region, Russia, 1999. Emerg. Infect. Dis.7:128-132.","journal-title":"Emerg. Infect. Dis."},{"key":"e_1_3_2_35_2","doi-asserted-by":"crossref","first-page":"3036","DOI":"10.1073\/pnas.022652799","volume":"99","year":"2002","unstructured":"Pletnev, A. G., R. Putnak, J. Speicher, E. J. Wagar, and D. W. Vaughn. 2002. West Nile virus\/dengue type 4 virus chimeras that are reduced in neurovirulence and peripheral virulence without loss of immunogenicity or protective efficacy. Proc. Natl. Acad. Sci. USA99:3036-3041. (Erratum, 99:7184.)","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"e_1_3_2_36_2","doi-asserted-by":"crossref","first-page":"4442","DOI":"10.1016\/j.vaccine.2005.03.042","volume":"23","year":"2005","unstructured":"Putnak, J. R., B.-A. Coller, G. Voss, D. W. Vaughn, D. Clements, I. Peters, G. Bignami, H.-S. Houng, R. C.-M. Chen, D. A. Barvir, J. Seriwatana, S. Cayphas, N. Gar\u00e7on, D. Gheysen, N. Kanesa-thasan, M. McDonell, T. Humphreys, K. H. Eckels, J.-P. Prieels, and B. L. Innis. 2005. An evaluation of dengue type-2 inactivated, recombinant subunit, and live attenuated vaccine candidates in the rhesus macaque model. Vaccine23:4442-4452.","journal-title":"Vaccine"},{"key":"e_1_3_2_37_2","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1016\/j.vaccine.2005.10.017","volume":"24","year":"2006","unstructured":"Quenelle, D. C., D. J. Collins, D. J. Marciani, and E. R. Kern. 2006. Effect of immunization with herpes simplex virus type-1 (HSV-1) glycoprotein D (gD) plus the immune enhancer GPI-0100 on infection with HSV-1 or HSV-2. Vaccine24:1515-1522.","journal-title":"Vaccine"},{"key":"e_1_3_2_38_2","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1086\/381461","volume":"189","year":"2004","unstructured":"Ratterree, M. S., R. A. Gutierrez, A. P. Travassos da Rosa, B. J. Dille, D. W. Beasley, R. P. Bohm, S. M. Desai, P. J. Didier, L. G. Bikenmeyer, G. J. Dawson, T. P. Leary, G. Schochetman, K. Phillippi-Falkenstein, J. Arroyo, A. D. Barrett, and R. B. Tesh. 2004. Experimental infection of rhesus macaques with West Nile virus: level and duration of viremia and kinetics of the antibody response after infection. J. Infect. Dis.189:669-676.","journal-title":"J. Infect. Dis."},{"key":"e_1_3_2_39_2","doi-asserted-by":"crossref","first-page":"557","DOI":"10.2987\/8756-971X(2006)22[557:BMIFMC]2.0.CO;2","volume":"22","year":"2006","unstructured":"Rodrigues, S. C., and J. E. Maruniak. 2006. Blood meal identification from mosquitoes collected at a commercial alligator farm. J. Am. Mosq. Control Assoc.22:557-560.","journal-title":"J. Am. Mosq. Control Assoc."},{"key":"e_1_3_2_40_2","doi-asserted-by":"crossref","first-page":"955","DOI":"10.4269\/ajtmh.2008.79.955","volume":"79","year":"2008","unstructured":"Siirin, M. T., A. P. A. Travassos da Rosa, P. Newman, C. Weeks-Levy, B.-A. Coller, S.-Y. Xiao, M. M. Lieberman, and D. M. Watts. 2008. Evaluation of the efficacy of a recombinant subunit West Nile vaccine in Syrian golden hamsters. Am. J. Trop. Med. Hyg.79:955-962.","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"e_1_3_2_41_2","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.3201\/eid0812.020229","volume":"8","year":"2002","unstructured":"Tesh, R. B., J. Arroyo, A. P. Travassos Da Rosa, H. Guzman, S. Y. Xiao, and T. P. Monath. 2002. Efficacy of killed virus vaccine, live attenuated chimeric virus vaccine, and passive immunization for prevention of West Nile virus encephalitis in hamster model. Emerg. Infect. Dis.8:1392-1397.","journal-title":"Emerg. Infect. Dis."},{"key":"e_1_3_2_42_2","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.00551-06"},{"key":"e_1_3_2_43_2","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1016\/S0140-6736(98)03538-7","volume":"352","year":"1998","unstructured":"Tsai, T. F., F. Popovici, C. Cernescu, G. L. Campbell, and N. I. Nedelcu. 1998. West Nile encephalitis epidemic in southeastern Romania. Lancet352:767-771.","journal-title":"Lancet"},{"key":"e_1_3_2_44_2","doi-asserted-by":"crossref","first-page":"2913","DOI":"10.1016\/j.vaccine.2006.08.008","volume":"25","year":"2007","unstructured":"Watts, D. M., R. B. Tesh, M. Siirin, A. Travassos da Rosa, P. C. Newman, D. E. Clements, S. Ogata, B.-A. Coller, C. Weeks-Levy, and M. M. Lieberman. 2007. Efficacy and durability of a recombinant subunit West Nile vaccine candidate in protecting hamsters from West Nile encephalitis. Vaccine25:2913-2918.","journal-title":"Vaccine"},{"key":"e_1_3_2_45_2","doi-asserted-by":"crossref","first-page":"714","DOI":"10.3201\/eid0704.017420","volume":"7","year":"2001","unstructured":"Xiao, S. Y., H. Guzman, H. Zhang, A. P. Travassos da Rosa, and R. B. Tesh. 2001. West Nile virus infection in the golden hamster (Mesocricetus auratus): a model for West Nile encephalitis. Emerg. Infect. Dis.7:714-721.","journal-title":"Emerg. Infect. Dis."},{"key":"e_1_3_2_46_2","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1016\/S0264-410X(02)00592-3","volume":"21","year":"2003","unstructured":"Zent, O., J. Beran., W. Jilg., T. Mach., and A. Banhoff. 2003. Clinical evaluation of a polygeline-free tick-borne encephalitis vaccine for adolescents and adults. Vaccine21:738-741.","journal-title":"Vaccine"}],"container-title":["Clinical and Vaccine Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/CVI.00119-09","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/CVI.00119-09","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,29]],"date-time":"2021-07-29T15:55:19Z","timestamp":1627574119000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.asm.org\/doi\/10.1128\/CVI.00119-09"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,9]]},"references-count":45,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2009,9]]}},"alternative-id":["10.1128\/CVI.00119-09"],"URL":"https:\/\/doi.org\/10.1128\/cvi.00119-09","relation":{},"ISSN":["1556-6811","1556-679X"],"issn-type":[{"value":"1556-6811","type":"print"},{"value":"1556-679X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,9]]},"assertion":[{"value":"2009-03-17","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2009-07-21","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-12-18","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}